Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Anti-adipogenic effects of the traditional herbal formula Dohongsamul-tang in 3T3-L1 adipocytes

Authors: Eun Hyoung Shim, Hoyoung Lee, Myeong Soo Lee, Sooseong You

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Blood stasis syndrome (BSS) is a general pattern identification and refers to pathological stagnation of blood circulation, dysfunction of endothelial cells or metabolic disorder in traditional Korean medicine (TKM). Dohongsamul-Tang (DHSMT) is a well-known traditional herbal formula which used for treatment and prevention of BSS by promoting blood circulation in TKM.

Methods

Cytotoxicity of DHSMT was examined by cell counting kit-8 (CCK-8). We also investigated the anti-adipogenesis effect of DHSMT by using Oil Red O staining, intracellular triglyceride assay leptin ELISA and western blot analysis in 3T3-L1 adipocytes. In addition, the accumulation of adiponectin, resistin and plasminogen activator inhibitor-1 (PAI-1) were measured by magnetic bead panel kit.

Results

Oil Red O staining showed that DHSMT markedly reduced fat accumulation without affecting cell cytotoxicity. DHSMT also significantly decreased accumulation of triglyceride and adipokines such as leptin, adiponectin, resistin and PAI-1 compared with fully differentiated adipocytes. Furthermore, our results found that DHSMT significantly suppressed the adipocyte differentiation by downregulating adipogenic-specific transcriptional factors such as peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer binding proteins alpha (C/EBPα) and fatty acid binding protein 4 (FABP4) in adipocytes.

Conclusions

Taken together, our findings provide that DHSMT has potential for treatment and prevention of obesity or MS related to BSS.
Literature
1.
go back to reference Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon. 1990;36(12):641–731.PubMed Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon. 1990;36(12):641–731.PubMed
2.
go back to reference Rose G. Population distributions of risk and disease. Nutr Metab Cardiovasc Dis. 1991;1:37–40. Rose G. Population distributions of risk and disease. Nutr Metab Cardiovasc Dis. 1991;1:37–40.
5.
go back to reference Li SM, Xu H, Chen KJ. The diagnostic criteria of blood-stasis syndrome: considerations for standardization of pattern identification. Chin J Integr Med. 2014;20:483–9.CrossRefPubMed Li SM, Xu H, Chen KJ. The diagnostic criteria of blood-stasis syndrome: considerations for standardization of pattern identification. Chin J Integr Med. 2014;20:483–9.CrossRefPubMed
6.
go back to reference Zhou XQ, Liang H, Sun X, Zhou HT. Correlation between TCM blood stasis pattern of coronary heart disease and coronary angiography result: a meta-analysis. Chin. J Evid Based Med. 2012;12(12):1470–7. Zhou XQ, Liang H, Sun X, Zhou HT. Correlation between TCM blood stasis pattern of coronary heart disease and coronary angiography result: a meta-analysis. Chin. J Evid Based Med. 2012;12(12):1470–7.
7.
go back to reference JI W, Zhou J, Wang S, Ji Z. Logistic regression analysis of relevance between different blood stasis syndromes and related factors in angina pectoris patients. Chin Arch Tradit Chin Med. 2013;7:40. JI W, Zhou J, Wang S, Ji Z. Logistic regression analysis of relevance between different blood stasis syndromes and related factors in angina pectoris patients. Chin Arch Tradit Chin Med. 2013;7:40.
8.
go back to reference Liu X, Guo C, Ma X, Tian R, Zhang Y, Yin H. Relationship between serum estrogen levels and blood stasis syndrome in postmenopausal women with coronary heart disease. Pak J Med Sci. 2015;31(1):25–30.PubMedPubMedCentral Liu X, Guo C, Ma X, Tian R, Zhang Y, Yin H. Relationship between serum estrogen levels and blood stasis syndrome in postmenopausal women with coronary heart disease. Pak J Med Sci. 2015;31(1):25–30.PubMedPubMedCentral
9.
go back to reference Yoon YG. Dohaejeongbo. Seoul: Eui Seing Dang Publ; 2007. p. 9–15. Yoon YG. Dohaejeongbo. Seoul: Eui Seing Dang Publ; 2007. p. 9–15.
10.
go back to reference Jeong WY, Jeon BH. Influence of medicinal herbal drug on the experimental model of thrombosis in animal. Korean J Oriental Pathol. 1996;10(1):72–8. Jeong WY, Jeon BH. Influence of medicinal herbal drug on the experimental model of thrombosis in animal. Korean J Oriental Pathol. 1996;10(1):72–8.
11.
go back to reference Jeong HY, Cho YL. The effect of DohongSamulTang(DST) on immune-system in L1210 cells-transplanted mice. Korean J Oriental Pathol. 1999;13(1):132–40. Jeong HY, Cho YL. The effect of DohongSamulTang(DST) on immune-system in L1210 cells-transplanted mice. Korean J Oriental Pathol. 1999;13(1):132–40.
12.
go back to reference You BS, Jung JE, Park JY, Yun JM, Lee I, Moon BS. Protective effects of dohongsamul-tang on zinc-mediated cytotoxicity in H9c2 cardiomyoblast cell. Korean J Oriental Physiol Pathol. 2004;18(5):1374–81. You BS, Jung JE, Park JY, Yun JM, Lee I, Moon BS. Protective effects of dohongsamul-tang on zinc-mediated cytotoxicity in H9c2 cardiomyoblast cell. Korean J Oriental Physiol Pathol. 2004;18(5):1374–81.
13.
go back to reference Chang SH, Lim EM, Lee E. Effects of Dohongsamul-tang on surgically induced endometriosis in rats. J Korean. Obstet Gynecol. 2006;19(1):125–35. Chang SH, Lim EM, Lee E. Effects of Dohongsamul-tang on surgically induced endometriosis in rats. J Korean. Obstet Gynecol. 2006;19(1):125–35.
14.
go back to reference Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem. 1998;273(48):32111–20.CrossRefPubMed Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem. 1998;273(48):32111–20.CrossRefPubMed
15.
go back to reference He Q, Huang C, Zhao L, Feng J, Shi Q, Wang D, Wang S. α-Naphthoflavone inhibits 3T3-L1 pre-adipocytes differentiation via modulating p38MAPK signaling. Int J Clin Exp Pathol. 2013;6(2):168–78.PubMedPubMedCentral He Q, Huang C, Zhao L, Feng J, Shi Q, Wang D, Wang S. α-Naphthoflavone inhibits 3T3-L1 pre-adipocytes differentiation via modulating p38MAPK signaling. Int J Clin Exp Pathol. 2013;6(2):168–78.PubMedPubMedCentral
16.
go back to reference Matsumoto C, Kojima T, Ogawa K, Kamegai S, Oyama T, Shibagaki Y, Kawasaki T, Fujinaga H, Takahashi K, Hikiami H, Goto H, Kiga C, Koizumi K, Sakurai H, Muramoto H, Shimada Y, Yamamoto M, Terasawa K, Takeda S, Saiki I. A proteomic approach for the diagnosis of ‘Oketsu’(blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine. Evid Based Complement Alternat Med. 2008;5(4):463–74.CrossRefPubMed Matsumoto C, Kojima T, Ogawa K, Kamegai S, Oyama T, Shibagaki Y, Kawasaki T, Fujinaga H, Takahashi K, Hikiami H, Goto H, Kiga C, Koizumi K, Sakurai H, Muramoto H, Shimada Y, Yamamoto M, Terasawa K, Takeda S, Saiki I. A proteomic approach for the diagnosis of ‘Oketsu’(blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine. Evid Based Complement Alternat Med. 2008;5(4):463–74.CrossRefPubMed
17.
go back to reference Chen KJ. Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med. 2012;18(12):891–6.CrossRefPubMed Chen KJ. Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med. 2012;18(12):891–6.CrossRefPubMed
18.
go back to reference Yu X, Zhang L, Xu H. Progress in research on relevant factors affecting TCM syndrome differentiation of CHD. Chin J Int Med Cardio/Cerebrovasc Dis. 2009;7(5):581–4. Yu X, Zhang L, Xu H. Progress in research on relevant factors affecting TCM syndrome differentiation of CHD. Chin J Int Med Cardio/Cerebrovasc Dis. 2009;7(5):581–4.
19.
go back to reference Zhu YB, Wang Q, CY W, Pang GM, Zhao JX, Shen SL, Xia ZY, Yan X. Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Chin J Integr Med. 2010;8(11):1023–8.CrossRef Zhu YB, Wang Q, CY W, Pang GM, Zhao JX, Shen SL, Xia ZY, Yan X. Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Chin J Integr Med. 2010;8(11):1023–8.CrossRef
20.
go back to reference Lu Y, Li T. Effect of Chinese drugs for activating blood circulation and removing blood stasis on carotid atherosclerosis and ischemic cerebrovascular events. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014;34(3):303–7.PubMed Lu Y, Li T. Effect of Chinese drugs for activating blood circulation and removing blood stasis on carotid atherosclerosis and ischemic cerebrovascular events. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014;34(3):303–7.PubMed
21.
go back to reference Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circ. 2002;106(3):286–8.CrossRef Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circ. 2002;106(3):286–8.CrossRef
22.
23.
go back to reference Zhang H, Shen P, Cheng Y. Identification and determination of the major constituents in traditional Chinese medicine Si-Wu-tang by HPLC coupled with DAD and ESI-MS. J Pharm Biomed Anal. 2004;34(3):705–13.CrossRefPubMed Zhang H, Shen P, Cheng Y. Identification and determination of the major constituents in traditional Chinese medicine Si-Wu-tang by HPLC coupled with DAD and ESI-MS. J Pharm Biomed Anal. 2004;34(3):705–13.CrossRefPubMed
24.
go back to reference Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M, Chen R. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol. 2004;150(6):885–92.CrossRefPubMed Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M, Chen R. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol. 2004;150(6):885–92.CrossRefPubMed
25.
go back to reference Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005;46(7):1369–79.CrossRefPubMed Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005;46(7):1369–79.CrossRefPubMed
26.
go back to reference Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab. 2006;290(1):E103–13.CrossRefPubMed Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab. 2006;290(1):E103–13.CrossRefPubMed
27.
go back to reference Yuan G, Jia J, Di L, Zhou L, Dong S, Ye J, Wang D, Yang L, Wang J, Li L, Yang Y, Mao C, Chen M. Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2012;424(3):462–8.CrossRefPubMed Yuan G, Jia J, Di L, Zhou L, Dong S, Ye J, Wang D, Yang L, Wang J, Li L, Yang Y, Mao C, Chen M. Effects of C-reactive protein on adipokines genes expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2012;424(3):462–8.CrossRefPubMed
28.
go back to reference Alvala R, Alvala M, Sama V, Dharmarajan S, Ullas JV, Reddy M. Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark. J Ethnopharmacol. 2013;148(2):441–8.CrossRefPubMed Alvala R, Alvala M, Sama V, Dharmarajan S, Ullas JV, Reddy M. Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark. J Ethnopharmacol. 2013;148(2):441–8.CrossRefPubMed
29.
go back to reference Houseknecht KL, Baile CA, Matteri RL, Spurlock ME. The biology of leptin: a review. J Anim Sci. 1998;76(5):1405–20.CrossRefPubMed Houseknecht KL, Baile CA, Matteri RL, Spurlock ME. The biology of leptin: a review. J Anim Sci. 1998;76(5):1405–20.CrossRefPubMed
30.
go back to reference DK O, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007;9(3):282–9.CrossRef DK O, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007;9(3):282–9.CrossRef
31.
go back to reference Guo L, Li X, Tang QQ. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 2015;290(2):755–61.CrossRefPubMed Guo L, Li X, Tang QQ. Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 2015;290(2):755–61.CrossRefPubMed
32.
go back to reference Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50(9):2094–9.CrossRefPubMed Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50(9):2094–9.CrossRefPubMed
33.
34.
go back to reference Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;276(14):11252–6.CrossRefPubMed Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001;276(14):11252–6.CrossRefPubMed
35.
go back to reference Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–12.CrossRefPubMed Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–12.CrossRefPubMed
36.
go back to reference Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator–activated receptor-γ action in humans. Diabetes. 2001;50(10):2199–202.CrossRefPubMed Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator–activated receptor-γ action in humans. Diabetes. 2001;50(10):2199–202.CrossRefPubMed
37.
go back to reference Senolt L, Housa D, Vernerova Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66(4):458–63.CrossRefPubMed Senolt L, Housa D, Vernerova Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007;66(4):458–63.CrossRefPubMed
38.
go back to reference Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost. 2004;91(5):861–72.PubMed Hoekstra T, Geleijnse JM, Schouten EG, Kluft C. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost. 2004;91(5):861–72.PubMed
39.
go back to reference Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 2004;53(2):336–46.CrossRefPubMed Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes. 2004;53(2):336–46.CrossRefPubMed
40.
go back to reference Mathieu P, Lemieux I, Després JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther. 2010;87(4):407–16.CrossRefPubMed Mathieu P, Lemieux I, Després JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther. 2010;87(4):407–16.CrossRefPubMed
41.
go back to reference Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, Gualillo O. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 2011;37(6):413–20.CrossRefPubMed Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, Gualillo O. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. Biofactors. 2011;37(6):413–20.CrossRefPubMed
42.
go back to reference Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 1998;273(46):30057–60.CrossRefPubMed Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 1998;273(46):30057–60.CrossRefPubMed
43.
go back to reference Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 2002;16(1):22–6.CrossRefPubMedPubMedCentral Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. C/EBPα induces adipogenesis through PPARγ: a unified pathway. Genes Dev. 2002;16(1):22–6.CrossRefPubMedPubMedCentral
44.
go back to reference Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 1999;3(2):151–8.CrossRefPubMed Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 1999;3(2):151–8.CrossRefPubMed
45.
go back to reference Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996;1302(2):93–109.CrossRefPubMed Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996;1302(2):93–109.CrossRefPubMed
46.
go back to reference Hou Y, Xue P, Bai Y, Liu D, Woods CG, Yarborough K, Fu J, Zhang Q, Sun G, Collins S, Chan JY, Yamamoto M, Andersen ME, Pi J. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. Free Radic Biol Med. 2012;52(2):462–72.CrossRefPubMed Hou Y, Xue P, Bai Y, Liu D, Woods CG, Yarborough K, Fu J, Zhang Q, Sun G, Collins S, Chan JY, Yamamoto M, Andersen ME, Pi J. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. Free Radic Biol Med. 2012;52(2):462–72.CrossRefPubMed
47.
48.
go back to reference MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995;64(1):345–73.CrossRefPubMed MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995;64(1):345–73.CrossRefPubMed
Metadata
Title
Anti-adipogenic effects of the traditional herbal formula Dohongsamul-tang in 3T3-L1 adipocytes
Authors
Eun Hyoung Shim
Hoyoung Lee
Myeong Soo Lee
Sooseong You
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-2038-z

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue